In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Ono, Masamichi ^a   Sawa, Yoshiki ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Kaneda, Yasufumi ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Gene therapy; Growth factor; Pulmonary vasculature; Remodeling

Indexed keywords

COMPLEMENTARY DNA; IMMUNOLIPOSOME; LIPOSOME; SCATTER FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTERY DISEASE; ARTICLE; ATTENUATION; BLOOD VESSEL PERMEABILITY; CAPILLARY DENSITY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG BLOOD VESSEL; LUNG PARENCHYMA; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; STATISTICAL SIGNIFICANCE; VIRUS HEMAGGLUTINATION;

ANIMALS; CAPILLARIES; ENDOTHELIUM, VASCULAR; FACTOR VIII; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; LASER-DOPPLER FLOWMETRY; LUNG; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ARTERY; PULMONARY CIRCULATION; RATS; RATS, WISTAR; TRANSFECTION; VASCULAR RESISTANCE;

EID: 0037167651     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mayer E, Dahm M, Hake U, et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 1996;61:1788-1792.
2. Kaulitz R, Ziemer G, Luhmer I, et al. Modified Fontan operation in functionally univentricular hearts: preoperative risk factors and intermediate results. J Thorac Cardiovasc Surg. 1996;112:658-664.
3. Heinemann MK, Hanley FL, Van Praagh SV, et al. Total anomalous pulmonary venous drainage in newborns with visceral heterotaxy. Ann Thorac Surg. 1994;57:88-91.
4. Losordo DW, Vale PR, Symes JF et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800-2804.
5. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF in patient with ischemic limb. Lancet. 1996;348:370-374.
6. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440-443.
7. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129:1177-1180.
8. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996;119:591-600.
9. Chan AM, Rubin JS, Bottaro DP, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802-804.
10. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992;16:1227-1235.
11. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-66.
12. Kawaida K, Matsumoto K, Shimizu H, et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357-4361.
13. Mizuno S, Kurosawa T, Matsumoto K, et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin. Invest. 1998;101:1827-1834.
14. Funatsu T, Sawa Y, Ohtake S, et al, Therapeutic angiogenesis induced by myocardial injection of naked cDNA plasmid encoding hepatocyte growth factor in ischemic canine heart. J Thorac Cardiovasc Surg. 2002;in press.
15. Nakamura T, Mizuno S, Matsumoto K, et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest. 2000;106:1511-1519.
16. Ohmichi H, Matsumoto K, Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am J Physiol. 1996;270:L1031-L1039.
17. Sakamaki Y, Matsumoto K, Mizuno S, et al. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol. 2002;26:525-533.
18. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 2000;7:417-427.
19. Taniyama Y, Morishita R, Aoki M, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181-189.
20. Seki T, Hagiya M, Shimonishi M, et al. Organization of human hepatocyte growth factor-encoding gene. Gene. 1991;102:213-219.
21. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA co-introduced with nuclear protein in adult rat liver. Science. 1989;243:375-378.
22. Keneda Y. Virus (Sendai virus envelopes)-mediated gene transfer. In: Celis JE, ed. Cell Biology: A Laboratory Handbook, Vol. III. New York, NY: Academic Press: 1994:50-57.
23. Schachtner SK, Rome JJ, Hoyt RF, et al. In vivo Adenovirus-Mediated gene transfer via the pulmonary artery of rats. Circ Res. 1995;76:701-709.
24. Ono M, Kishimoto H, Kawata H, et al. Usefulness of pulmonary artery clamp test for the evaluation of pulmonary vascular resistance in isomerism heart with pulmonary venous obstruction. Ped Cardiol Card Surg. 2001;17:709-714.
25. Tsao MS, Yang Y, Marcus A, et al. Hepatocyte growth factor is predominantly expressed by carcinoma cells in non-small-cell lung cancer. Hum Pathol. 2001;32:57-65.
26. Duan J, Murohara T, Ikeda H, et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia nitric oxide-dependent mechanism. Circulation 2000;102(suppl III):III-370-III-376.
27. Maemondo M, Narumi K, Saijo Y, et al. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol Ther. 2000;5:177-185.
28. Yi S, Tsao MS. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia. 2000;2:226-234.
29. Dunkan BW, Kneebone JM, Chi EY, et al. A detailed histologic analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg. 1999;117:931-938.
30. Budts W, Pokreisz P, Nong Z, et al. Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation. 2000;102:2880-2885.
31. Nagaya N, Yokoyama C, Kyotani S, et al. Gene transfer of human prostacycline synthase ameliorates monocrotaline-induced pulmonary hypertension in rats. Circulation. 2000;102:2005-2010.
32. Champion HC, Bivalacqua TJ, Toyoda K, et al. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation. 2000;101:923-930.
33. Jeppsson A, Pellegrini C, Lee R, et al. Improved efficiency of gene transfer to the transplanted lung by retrograde vascular gene delivery. Transpl Int. 2000;13:241-6.
34. Suzuki K, Sawa Y, Kaneda Y, et al. In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat. J Clin Invest. 1997;99:1645-1650.
35. Tsuboniwa N, Morishita R, Hirano T, et al. Safety evaluation of hemagglutinating virus of Japan-artificial viral envelope liposomes in nonhuman primates. Hum Gene Ther. 2001;12:469-487.